A citation-based method for searching scientific literature

Yujiro Kidani, Wataru Nogami, Yoshiaki Yasumizu, Atsunari Kawashima, Atsushi Tanaka, Yudai Sonoda, Yumi Tona, Kunitaka Nashiki, Reimi Matsumoto, Masaki Hagiwara, Motonao Osaki, Keiji Dohi, Takayuki Kanazawa, Azumi Ueyama, Mai Yoshikawa, Tetsuya Yoshida, Mitsunobu Matsumoto, Kanji Hojo, Satomi Shinonome, Hiroshi Yoshida, Michinari Hirata, Miya Haruna, Yamami Nakamura, Daisuke Motooka, Daisuke Okuzaki, Yasuko Sugiyama, Makoto Kinoshita, Tatsusada Okuno, Taigo Kato, Koji Hatano, Motohide Uemura, Ryoichi Imamura, Kazunori Yokoi, Atsushi Tanemura, Yasushi Shintani, Tadashi Kimura, Norio Nonomura, Hisashi Wada, Masaki Mori, Yuichiro Doki, Naganari Ohkura, Shimon Sakaguchi. Proc Natl Acad Sci U S A 2022
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer.
George Plitas, Catherine Konopacki, Kenmin Wu, Paula D Bos, Monica Morrow, Ekaterina V Putintseva, Dmitriy M Chudakov, Alexander Y Rudensky. Immunity 2016
322
66

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
Matthew G Oser, Matthew J Niederst, Lecia V Sequist, Jeffrey A Engelman. Lancet Oncol 2015
477
33

Identification of human CCR8 as a CCL18 receptor.
Sabina A Islam, Morris F Ling, John Leung, Wayne G Shreffler, Andrew D Luster. J Exp Med 2013
108
33

Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC.
Jialin Qu, Man Jiang, Li Wang, Deze Zhao, Kang Qin, Yun Wang, Junyan Tao, Xiaochun Zhang. Biomed Pharmacother 2020
16
33

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review.
Bagher Farhood, Masoud Najafi, Keywan Mortezaee. J Cell Physiol 2019
438
33

Regulatory T cells in cancer immunotherapy.
Atsushi Tanaka, Shimon Sakaguchi. Cell Res 2017
691
33

PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
Masaaki Sawada, Kumiko Goto, Akiko Morimoto-Okazawa, Miya Haruna, Kei Yamamoto, Yoko Yamamoto, Satoshi Nakagawa, Kosuke Hiramatsu, Shinya Matsuzaki, Eiji Kobayashi,[...]. Int Immunol 2020
11
33

Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
Xinyi Guo, Yuanyuan Zhang, Liangtao Zheng, Chunhong Zheng, Jintao Song, Qiming Zhang, Boxi Kang, Zhouzerui Liu, Liang Jin, Rui Xing,[...]. Nat Med 2018
507
33


FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity.
Theresa L Whiteside. Expert Opin Ther Targets 2018
58
33

FOXP3+ regulatory T cells in the human immune system.
Shimon Sakaguchi, Makoto Miyara, Cristina M Costantino, David A Hafler. Nat Rev Immunol 2010
33



Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review.
Keisuke Onoi, Yusuke Chihara, Junji Uchino, Takayuki Shimamoto, Yoshie Morimoto, Masahiro Iwasaku, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama. J Clin Med 2020
42
33

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.
K L Knutson, M L Disis. Cancer Immunol Immunother 2005
468
33

Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
Joseph R Campbell, Bryan R McDonald, Paul B Mesko, Nathan O Siemers, Priti B Singh, Mark Selby, Tim W Sproul, Alan J Korman, Logan M Vlach, Jeff Houser,[...]. Cancer Res 2021
16
33

Regulatory T cells in cancer immunotherapy.
Hiroyoshi Nishikawa, Shimon Sakaguchi. Curr Opin Immunol 2014
446
33

GSVA: gene set variation analysis for microarray and RNA-seq data.
Sonja Hänzelmann, Robert Castelo, Justin Guinney. BMC Bioinformatics 2013
33

Role of regulatory T cells in human diseases.
Talal A Chatila. J Allergy Clin Immunol 2005
185
33

A guide to chemokines and their receptors.
Catherine E Hughes, Robert J B Nibbs. FEBS J 2018
341
33

Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.
Helena Van Damme, Bruno Dombrecht, Máté Kiss, Heleen Roose, Elizabeth Allen, Eva Van Overmeire, Daliya Kancheva, Liesbet Martens, Aleksandar Murgaski, Pauline Madeleine Rachel Bardet,[...]. J Immunother Cancer 2021
21
33

Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
Daisuke Sugiyama, Hiroyoshi Nishikawa, Yuka Maeda, Megumi Nishioka, Atsushi Tanemura, Ichiro Katayama, Sachiko Ezoe, Yuzuru Kanakura, Eiichi Sato, Yasuo Fukumori,[...]. Proc Natl Acad Sci U S A 2013
421
33

Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells.
Marco De Simone, Alberto Arrigoni, Grazisa Rossetti, Paola Gruarin, Valeria Ranzani, Claudia Politano, Raoul J P Bonnal, Elena Provasi, Maria Lucia Sarnicola, Ilaria Panzeri,[...]. Immunity 2016
309
33

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
33

Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
Daniel O Villarreal, Andrew L'Huillier, Susan Armington, Cristina Mottershead, Elena V Filippova, Brandon D Coder, Robert G Petit, Michael F Princiotta. Cancer Res 2018
59
33

Roles of regulatory T cells in cancer immunity.
Yoshiko Takeuchi, Hiroyoshi Nishikawa. Int Immunol 2016
274
33

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
David P Carbone, Martin Reck, Luis Paz-Ares, Benjamin Creelan, Leora Horn, Martin Steins, Enriqueta Felip, Michel M van den Heuvel, Tudor-Eliade Ciuleanu, Firas Badin,[...]. N Engl J Med 2017
33

Global Cancer Incidence and Mortality Rates and Trends--An Update.
Lindsey A Torre, Rebecca L Siegel, Elizabeth M Ward, Ahmedin Jemal. Cancer Epidemiol Biomarkers Prev 2016
33

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.
Koji Kurose, Yoshihiro Ohue, Hisashi Wada, Shinsuke Iida, Takashi Ishida, Takashi Kojima, Toshihiko Doi, Susumu Suzuki, Midori Isobe, Takeru Funakoshi,[...]. Clin Cancer Res 2015
141
33

CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
Tao Wang, Quan Zhou, Han Zeng, Hongyu Zhang, Zhaopei Liu, Jialiang Shao, Zewei Wang, Ying Xiong, Jiajun Wang, Qi Bai,[...]. Cancer Immunol Immunother 2020
14
33

Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
G J Gordon, M Mani, L Mukhopadhyay, L Dong, B Y Yeap, D J Sugarbaker, R Bueno. J Pathol 2007
50
33

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

Merkel cell carcinoma induces lymphatic microvessel formation.
Siegfried Werchau, Ferdinand Toberer, Alexander Enk, Reinhard Dammann, Peter Helmbold. J Am Acad Dermatol 2012
33
33

Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor.
Zuzanna Drebert, Mark MacAskill, Dahlia Doughty-Shenton, Karolien De Bosscher, Marc Bracke, Patrick W F Hadoke, Ilse M Beck. Vascul Pharmacol 2017
17
33

Escin inhibits angiogenesis by suppressing interleukin‑8 and vascular endothelial growth factor production by blocking nuclear factor‑κB activation in pancreatic cancer cell lines.
Kan Omi, Yoichi Matsuo, Goro Ueda, Yoshinaga Aoyama, Tomokatsu Kato, Yuichi Hayashi, Hiroyuki Imafuji, Kenta Saito, Ken Tsuboi, Mamoru Morimoto,[...]. Oncol Rep 2021
4
33

TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.
Gianluca Storci, Pasquale Sansone, Sara Mari, Gabriele D'Uva, Simona Tavolari, Tiziana Guarnieri, Mario Taffurelli, Claudio Ceccarelli, Donatella Santini, Pasquale Chieco,[...]. J Cell Physiol 2010
134
33

Research progress of phenolic compounds regulating IL-6 to exert antitumor effects.
Tingting Xia, Jie Li, Xin Ren, Cun Liu, Changgang Sun. Phytother Res 2021
3
33

Cancer-related inflammation.
Alberto Mantovani, Paola Allavena, Antonio Sica, Frances Balkwill. Nature 2008
33

Anoikis: an emerging hallmark in health and diseases.
M L Taddei, E Giannoni, T Fiaschi, P Chiarugi. J Pathol 2012
252
33

Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling.
You-Take Oh, Shi-Yong Sun. Biomolecules 2021
3
33

Propofol-enhanced autophagy increases motility and angiogenic capacity of cultured human umbilical vascular endothelial cells.
Chih-Yang Chang, Po-Han Chen, Shang-Chieh Lu, Ming-Chu Hsieh, Chia-Wei Lin, Hui-Ming Lee, Bruno Jawan, Ying-Hsien Kao. Life Sci 2015
13
33



VEGF inhibition in urothelial cancer: the past, present and future.
Sanaz Ghafouri, Aaron Burkenroad, Morgan Pantuck, Bara Almomani, Dimitris Stefanoudakis, John Shen, Alexandra Drakaki. World J Urol 2021
4
33

Tumour necrosis factor and cancer.
Frances Balkwill. Nat Rev Cancer 2009
33

Cytokine Regulation of Metastasis and Tumorigenicity.
M Yao, G Brummer, D Acevedo, N Cheng. Adv Cancer Res 2016
53
33

The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target.
Antonio Faiella, Ferdinando Riccardi, Giacomo Cartenì, Martina Chiurazzi, Livia Onofrio. J Oncol 2022
3
33

Tumor Necrosis Factor-α in Heart Failure: an Updated Review.
Sarah M Schumacher, Sathyamangla V Naga Prasad. Curr Cardiol Rep 2018
54
33

Interleukins in cancer: from biology to therapy.
Daria Briukhovetska, Janina Dörr, Stefan Endres, Peter Libby, Charles A Dinarello, Sebastian Kobold. Nat Rev Cancer 2021
56
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.